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Isolation frequency and susceptibility pattern of 
non-O1 and non-O139 Vibrio cholerae in a tertiary 
health care laboratory, 1999–2012
S. lrfan,1 N. Fasih,1 N.K. Ghanchi 1 and E. Khan 1
ABSTRACT In the past decade the importance of non-O1 and non-O139 strains of Vibrio cholerae has been 
highlighted globally. This study aimed to evaluate the frequency and antimicrobial susceptibility profile of 
non-O1 and non-O139 V. cholerae in Pakistan. Data of stool specimens yielding growth of non-O1 and non-O139 
V. cholerae isolated at a national referral laboratory from 1999 to 2012 were retrospectively analysed and evaluated 
for resistance to ampicillin, tetracycline, chloramphenicol, co-trimoxazole and ofloxacin. A total of 95 800 stool 
samples submitted over 1999–2012 yielded 3668 strains of V. cholerae, of which 6% were non-O1 and non-O139 
V. cholerae. A high isolation rate was found in the summer season, with a peak in the year 2003. Antimicrobial 
susceptibility data revealed increasing resistance to co-trimoxazole and ampicillin, but strains remained highly 
susceptible to ofloxacin. Active surveillance of serotypes and antimicrobial susceptibility is essential to predict 
future epidemics and define measures to curtail the disease.
 ةرـفلا في ،ةـيثلاثلا ةـيحصلا ةـياعرلا تارـتمخ دـحأ في O139 اـلاو O1 اـلا ارـلوكلا تاـض ةيـساسح طاـنأ لزـع ددرـت
2012-1999 نـب اـم
ناخ امورإ ،شيناغ ميرك ةيجن ،حيسف ةميعن ،نافرع مايس
 ةـساردلا هذـه تـفده دـقو .O139 اـلاو O1 اـلا ارـلوكلا تماـض تلااـس ةـيهمأ ىـع ضياـلما دـقعلا في - ًاـيلماع - ءوـضلا طلـُس دـقل :ةـصالخا
 زارـلا تاـنيع تاـنايبل يداعتـسا لـيلتح يرـجأف .ناتـسكاب في ةـيودلأل اهتيـساسح طماـنأو O139 اـلاو O1 اـلا ارـلوكلا لزـع رارـكت مـييقت لىإ
 تـمِّيقو ،2012 ماـع لىإ 1999 ماـع نـم يـنطو تلااـحإ رـتمخ في تـلزُع يـتلاو O139 اـلاو O1 اـلا ارـلوكلا تماـضل وـمن اـهيف ثدـح يـتلا
 لاـ خ ةـ م َّدقلما زارـ لا تاـ نيع تـ جتنأ دـ قل .نـ ساسكولفولأاو لوزاـ سكوميرتوكلاو لوـ كينيفمارولكلاو نلكيـ ساترتلاو نليـ سيبملأل اـ هتمواقم
 ارـلوك تماـض اـهنم 6% ناك ،ارـلوكلا ةـمض تلااـس نـم ةلاـس 3668 هـعوممج اـم ةـنيع 95800 اـهعوممج غـلب يـتلاو 2012-1999 ماوـعلأا
 تاـبوركيلما ةيـساسح تاـنايب ترـهظأو .2003 ماـع في هـتورذ غـلبو ،فـيصلا لـصف في ًاـعفترم ناك لزـعلا لدـعم نأ دـجوو .O139 لاو O1 لا
 ماـيقلا يرورـلا نـم هـنإ .نـساسكولفولأل ةـساسح اـهئاقب عـم ،نليـسيبملأاو لوزاـسكوميرتوكلل يرارذـلا هذـه ةـمواقم في ةداـيز ةـيودلأل
.ضرـلما نـم دـحلل ةـمزالا رـبادتلا دـيدتحو ةيلبقتـسلما ةـئبولأاب ؤـبنتلا لـجأ نـم ،ةـيودلأل اهتيـساسلحو ةـيلصلما طماـنلأل طـشن دـصترب
Fréquence d’isolation et profil de sensibilité de Vibrio cholerae non-O1 et non-O139 dans un laboratoire de 
soins de santé tertiaires, 1999-2012
RÉSUMÉ Au cours des dix dernières années, l’importance des souches de Vibrio cholerae non-O1 et non-O139 a été 
mise en avant à l’échelle mondiale. La présente étude visait à évaluer la fréquence de l'isolation des souches de Vibrio 
cholerae non-O1 et non-O139 et leur profil de sensibilité aux antimicrobiens au Pakistan. Les données d'échantillons 
de selles ayant permis la croissance de V. cholerae non-O1 et non-O139 isolés dans un laboratoire national spécialisé 
entre 1999 et 2012 ont été analysées et évaluées rétrospectivement pour leur résistance à l’ampicilline, la tétracycline, au 
chloramphénicol, au co-trimoxazole et à l’ofloxacine. Au total, 95 800 échantillons de selles soumis entre 1999 et 2012 
ont produit 3668 souches de V. cholerae, parmi lesquelles 6 % étaient des souches de V. cholerae non-O1 et non-O139. 
Un taux d’isolation élevé a été observé au cours de l’été, avec un pic en 2003. Les données relatives à la sensibilité aux 
antimicrobiens ont révélé une augmentation de la résistance au co-trimoxazole et à l’ampicilline, mais les souches 
restaient fortement sensibles à l’ofloxacine. Une surveillance active des sérotypes et de la sensibilité aux antimicrobiens 
est essentielle pour prévenir les épidémies et définir des mesures permettant d'enrayer la maladie.
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Introduction
Food- and water-borne illnesses are 
leading public health problems around 
the world. Although in developed coun-
tries the predominant bacterial causes 
of diarrhoea include pathogens such as 
Salmonella and Campylobacter spp. (1), 
in developing countries Vibrio cholerae 
still remains the top cause of watery di-
arrhoea (2). V. cholerae is classified to 
over 200 serotypes on the basis of varia-
tions in the lipopolysaccharide somatic 
antigen (3). V. cholerae belonging to 
serogroups O1 and O139 has been 
associated with epidemics and pan-
demics of cholera due to production of 
cholera toxin (2–5). Other serotypes 
are collectively known as non-O1 and 
non-O139 or non-typeable V. cholerae. 
A majority of these strains are usually 
responsible for sporadic cases of diar-
rhoea (6–8). However, the pathogenic 
potential of non-O1 and non-O139 V. 
cholerae should not be underestimated 
as some strains are clearly pathogenic, 
due either to cholera toxin production 
or to other virulence factors such as 
heat-stable enterotoxin, haemolysin, 
repeats-in-toxin and type 3 secretion 
systems (7). Occasionally, these strains 
are responsible for outbreaks of chol-
era (9–11). According to the United 
States Centers for Disease Control and 
Prevention (CDC), non-O1 and non-
O139 V. cholerae are the third most 
commonly reported group of Vibrio 
spp., and since the year 2000 they ac-
counted for around 40 cases of diar-
rhoea per year reported to the CDC 
(12). Moreover, in immunocompro-
mised people these bacteria have been 
associated with a severe form of disease 
that may lead to sepsis and other life-
threatening conditions (13–15). The 
susceptibility pattern of these reported 
isolates are diverse, showing a varying 
prevalence of different serovars in dif-
ferent regions.
In Pakistan V. cholerae O1 is one of 
the commonest organisms responsi-
ble for diarrhoeal outbreaks (16). An 
outbreak of O139 was also reported 
in 2002 (5). However, data on the iso-
lation rate and antibiotic susceptibil-
ity pattern of non-O1 and non-O139 
V. cholerae are lacking. Such data are 
valuable for the empirical treatment 
of patients in special circumstances 
and to compare with reports from 
other countries. This study therefore 
aimed to evaluate the frequency and 
antimicrobial profile of non-O1 and 
non-O139 V. cholerae in Pakistan 
from stool samples over the years 
1999–2012.
Method
Study design and setting
This was a retrospective analysis of 
antimicrobial resistance among non-
O1 and non-O139 V. cholerae strains 
isolated at the clinical microbiology 
laboratory of Aga Khan University hos-
pital in Karachi, Pakistan, for diagnostic 
purposes. This laboratory caters for 
inpatients as well as outside referrals 
from other hospitals, clinics and gen-
eral practitioners across the country. 
All 95 800 stool samples submitted 
to the laboratory for analysis from the 
years 1999 to 2012 were included in 
the study.
The study protocol and consent 
procedures were approved by the eth-
ics review committee of the Aga Khan 
University Hospital. Specific verbal or 
written consent from patients was not 
required as the data used were obtained 
from laboratory records and used 
anonymously.
Data collection
All stool samples for culture were pro-
cessed according to standard practice 
and were inoculated on the following 
media: MacConkey, Salmonella-
Shigella, Campylobacter and tellurite 
taurocholate gelatin agar (TTGA) 
(Oxoid). Stool samples were also in-
oculated in selenite F broth and alka-
line-peptone water and sub-cultured 
on solid media after overnight incuba-
tion. Suspected colonies from TTGA 
were biochemically confirmed using 
analytical profile index 20 Enterobac-
teriaceae (API 20 E) (BioMerieux). 
V. cholerae  O1 serogroups were 
performed using polyvalent O1 an-
tisera, for Ogawa and Inaba strains 
(Murex Diagnostic) and serogroup 
O139 (Dienka Sieken). Non-O1 and 
non-O139 V. cholerae were reported 
when an isolate had a biochemical 
profile (using API 20 E) of V. cholerae 
but failed to agglutinate by V. cholerae 
antisera O1 and O139.
Antimicrobial drug susceptibility 
assay was performed by the disk diffu-
sion method using commercially avail-
able disks (Becton Dickinson; Sparks 
Glencoe). The antibiotics tested were: 
ampicillin (10 µg), tetracycline (30 µg), 
co-trimoxazole (1.25/23.75 µg), chlo-
ramphenicol (30 µg) and ofloxacin (5 
µg). Since there were no interpretive 
breakpoints for V. cholerae available in 
the Clinical and Laboratory Standard 
Institute guidelines, breakpoints for 
Enterobacteriaceae were adopted for 
V. cholerae (17). Escherichia coli (ATCC 
25922) strain was used as a quality con-
trol.
Data management and 
statistical analysis
Data extracted from the computer-
ized information system of the hos-
pital were transferred to the statistical 
software SPSS, version 19.0. Frequen-
cies with percentages for age, seasonal 
distribution and isolation rate were 
analysed. The resistance pattern of 
non-O1 and non-O139 V. cholerae 
was evaluated among different age 
groups.
Results
During the study period (1999–2012), 
a total of 95 800 stool samples for 
culture and susceptibility testing were 
processed at the Aga Khan University 
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Hospital laboratory. The yield of 
positive samples (isolation of at least 
1 diarrhoea-causing bacterial pathogen 
including Salmonella spp., Shigella spp., 
V. cholerae, Campylobacter spp. and 
Aeromonas spp.) was 20 125 (21%). 
Out of these positive cultures 3668 
isolates (18%) were V. cholerae group 
(Table 1). Throughout the study 
period (1999–2012) V. cholerae O1 
serogroups remained the predominant 
strain but a changing trend from sero-
type Ogawa to Inaba was seen in the 
years 2005–6 and 2012 respectively 
and again from Inaba to Ogawa was 
seen in 2007 (Table 1). V. cholerae 
O139 serogroup emerged only in the 
years 2000–2002.
Of the total V. cholerae isolates, 233 
(6%) failed to show agglutination by 
O1 (Ogawa, Inaba) and O139 anti-
sera. These isolates were confirmed as 
V. cholerae by API 20E, and reported 
as non-O1 and non-O139 V. chol-
erae. Table 1 shows the annual rate of 
isolation of non-O1 and non-O139 
V. cholerae over the study period; the 
highest number of cases were seen in 
the year 2003.
The majority of stool cultures yield-
ing non-O1 and non-O139 V. cholerae 
(98%) were submitted from different 
locations of Karachi city. From other 
locations 1% were isolated from Hy-
derabad and 0.7% and 0.3% were from 
Mir Pur Khas and Jacobad respec-
tively. Demographic data showed that 
122 cases (52%) of non-O1 and non-
O139 V. cholerae were in children aged 
≤ 14 years and 111 (48%) in those 
aged > 14 years old, and more cases 
were in males (135, 58%) than females 
(98, 42%). Seasonal variations in isola-
tion frequency were observed, with 
the few or no isolates during winter 
and a maximum rate during summer 
with peaks from May to August each 
year (Figure 1).
The annual trend of antimicrobial 
susceptibility data revealed increasing 
resistance to antibiotics such as co-
trimoxazole and ampicillin. The lowest 
rate of resistance was observed against 
ofloxacin, followed by tetracycline 
and chloramphenicol, as shown in 
Figure 2. Table 2 shows that for most 
antibiotics antimicrobial resistance 
rates were similar between children 
and older age groups, except for co-
trimoxazole which showed higher 
resistance among children aged ≤ 14 
years than adolescent/adults aged > 
14 years (52% versus 33%).
Discussion
To the best of our knowledge this is 
the first study reporting the frequency 
of non-O1 and non-O139 V. chol-
erae from clinical samples tested at 
a diagnostic laboratory of Pakistan. 
We found that the rate of non-O1 
and non-O139 V. cholerae remained 
at a low level (≤ 10%) of the total V. 
cholerae group throughout the study 
period except from 2002 to 2004 
where an upsurge was observed from 
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Figure 1 Monthly isolation frequency of non-O1 and non-O139 Vibrio cholerae from 1999–2012
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13% to 27%, with a prominent surge 
in the year 2003.
Our findings of a low isolation rate 
of non-O1 and non-O139 V. chol-
erae from clinical samples (overall 6% 
of total V. cholerae) is consistent with 
the sporadic form of diarrhoea caused 
by endemic strains of non-O1 and non-
O139 V. cholerae reported from other 
countries in the region. A literature 
search showed Indian studies report-
ing variable isolation frequencies of 
non-O1 and non-O139 V. cholerae 
from clinical samples. For example, 4% 
and 5% isolation rates of non-O1 and 
non-O139 V. cholerae were reported 
from Sevagram in Maharashtra state 
and Delhi respectively (18,19), and 
higher isolation rates of 13% and 24% 
from Kolkata and Hubli respectively 
(17,20). Similarly, reports from Thai-
land showed a lower rate of up to 3% 
of non-O1 and non-O139 V. cholerae 
among V. cholerae isolates (21).
The increase in frequency of non-
O1 and non-O139 V. cholerae noted 
in 2003 is suggestive of a possible 
outbreak in that year. Non-O1 and 
non-O139 V. cholerae strains detected 
during that period also had unique 
features of co-trimoxazole resistance 
of 100% compared with a baseline of 
35–40% (Figure 2). A plausible asso-
ciation of this high isolation rate could 
be related to heavy rainfalls leading to 
nationwide flooding in 2003. These 
findings are suggestive of a possible 
emergence of a novel strain with a 
unique antibiogram, and perhaps 
increased pathogenicity, leading to 
symptomatic disease. Due to the ret-
rospective nature of the study we were 
not been able to perform molecular 
strain typing and could not retrieve 
clinical data to confirm the outbreak 
situation with the novel strain.
Interestingly a majority of non-O1 
and non-O139 V. cholerae strains were 
isolated from stool samples received 
from Karachi, a coastal city which has 
a questionable supply of clean drink-
ing water and high rates of enteric 
fever and other gastrointestinal in-
fections in the community (22,23). 
Additionally a lack of proper surveil-
lance of diarrhoeal outbreaks leads 
to paucity of data. Similar upsurges 
Table 1 Annual isolation rate of non-O1and non-O139 Vibrio cholerae at Aga Khan University clinical laboratory; 1999–2012
Year of culture 
testing
Stool 
culture 
performed
Stool 
culture 
growing 
diarrhoeal 
pathogens
V. cholerae 
among 
diarrhoeal 
pathogens
V. cholerae strains
O1 
(Ogawa)
O1 
(Inaba)
O139 Non-O1 
and 
non-O139
No. No. No. No. No. No. No. %
1999 4 807 841 317 282 31 0 4 1
2000 4 806 735 271 213  1 39 18 7
2001 5 587 1 108 412 325 2 81 4 1
2002 8 062 1 334 229 142 3 55 29 13
2003 9 943 2 063 262 182 9 2 69 27
2004 4 700 851 98 64 19 1 14 14
2005 5 556 2 473 738 2 721 0 15 2
2006 6 103 1 441 188 0 181 0 7 4
2007 6 365 1 084 286 149 122 0 15 5
2008 8 267 1 884 238 219 3 0 16 7
2009 9 999 2 667 248 223 5 0 20 8
2010 7 224 1 343 155 143 3 0 9 6
2011 7 597 1 294 152 136 10 0 6 4
2012 6 784 1 007 74 15 52 0 7 10
Total 95 800 20 124 3668 2095 1162 178 233 6
Table 2 Frequency of non-O1 and non-O139 Vibrio cholerae isolation and antimicrobial resistance rates, by age group
Age (years) Isolation 
frequency
Antimicrobial resistance
Co-trimoxazole Ampicillin Tetracycline Chloramphenicol Ofloxacin
No. No. % No % No % No % No %
≤ 14 122 63 52 12 10 1 1 4 3 0 0
> 14 111 37 33 13 12 4 4 0 0 1 1
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in the isolation rate of non-O1 and 
non-O139 V. cholerae have been re-
ported from India during the period 
2002–04, showing replacement of 
predominant V. cholerae O1 serotypes 
(20). These findings suggest the pos-
sibility of a regional outbreak with 
novel serotypes and emphasizes the 
need for continuous surveillance and 
monitoring of regional diarrhoeal 
strains.
Throughout the duration of 
the current study (1999–2012) V. 
cholerae O1 serogroups remained 
the predominant serotype. Another 
interesting finding of our study is re-
lated to V. cholerae O139. It seems 
that a new serotype with a different 
antibiogram (5) had emerged in the 
year 2000–02. This is comparable 
with the similar trend reported from 
India (19). Further comparison of 
previously published antimicrobial 
susceptibility data of V. cholerae O139 
from Pakistan (5) is comparable with 
India (19) and strains from both 
regions had a similar susceptibil-
ity pattern to reported antimicrobi-
als including co-trimoxazole (5,19). 
This again highlights the likelihood 
of circulation of particular type of V. 
cholerae O139 in the Indian subconti-
nent during that period. Non-O1 and 
non-O139 V. cholerae were likely to be 
the origin of the new virulence gene, 
as emergence of the O139 serovar 
resulted due to horizontal gene trans-
fer between V. cholerae O1 and O22 
(24,25). Therefore, continuous moni-
toring of these serovars will provide 
valuable information on mechanisms 
of virulence.
Finally, the current data showed 
a fluctuating pattern of susceptibil-
ity from year to year of non-O1 and 
non-O139 V. cholerae isolates to the 
antibiotics commonly used against 
cholera. Low resistance to tetracy-
cline was seen except in the year 
2012. Resistance to co-trimoxazole 
peaked in 2003 and 2012. Therefore 
with empirical use of World Health 
Organization recommended drugs 
such as tetracycline and doxycycline 
intended for treatment of cholera, 
continuous monitoring of antimicro-
bial resistance surveillance should be 
maintained.
Conclusion
In conclusion, this study found that, 
despite annual fluctuations, the rate of 
non-O1 and non-O139 V. cholerae re-
mained a significant cause of diarrhoeal 
illness in Pakistan, as it is in neighbour-
ing regions, with the possibility of 
emergence of novel pathogenic strains. 
These findings emphasize the need for 
continuous surveillance of serotypes 
and monitoring of antimicrobial resist-
ance of regional diarrhoeal strains to 
predict future epidemics and define 
measures to curtail the disease. Surveil-
lance data will also provide baseline 
information to develop empirical an-
tibiotic choice, effective vaccines and 
preventive strategies.
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